QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
OTCMKTS:CLIGF

Clinigen Group Stock Forecast, Price & News

$8.40
0.00 (0.00 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$8.40
Now: $8.40
$8.40
50-Day Range
$8.10
MA: $8.35
$8.75
52-Week Range
$6.00
Now: $8.40
$12.30
VolumeN/A
Average Volume30 shs
Market Capitalization$1.03 billion
P/E Ratio10.37
Dividend YieldN/A
Beta0.85
Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines. The Unlicensed Medicines segment is involved in sourcing and supplying unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Services segment packages, supplies, distributes, and manages comparator medicines and services to clinical trials and investigator initiated trials. It offers Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals which work by stopping viruses from multiplying in number; AZEDR for the treatment of adult and pediatric patients; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.
Read More
Clinigen Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.78 out of 5 stars

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CLIGF
Previous SymbolNASDAQ:CLIGF
CUSIPN/A
CIKN/A
Phone44-12-8349-5010
Employees1,150

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$635.82 million
Cash Flow$1.48 per share
Book Value$4.59 per share

Profitability

Miscellaneous

Market Cap$1.03 billion
Next Earnings Date12/17/2020 (Estimated)
OptionableNot Optionable
$8.40
0.00 (0.00 %)
(As of 10/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLIGF News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIGF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Clinigen Group (OTCMKTS:CLIGF) Frequently Asked Questions

How has Clinigen Group's stock been impacted by COVID-19?

Clinigen Group's stock was trading at $9.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLIGF stock has decreased by 6.7% and is now trading at $8.40.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Clinigen Group?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Clinigen Group
.

When is Clinigen Group's next earnings date?

Clinigen Group is scheduled to release its next quarterly earnings announcement on Thursday, December 17th 2020.
View our earnings forecast for Clinigen Group
.

Who are some of Clinigen Group's key competitors?

Who are Clinigen Group's key executives?

Clinigen Group's management team includes the following people:
  • Mr. Shaun Edward Chilton, CEO & Exec. Director (Age 52)
  • Mr. Nicholas P. Keher, CFO & Exec. Director
  • Ms. Debra Ainge, Chief Operating Officer
  • Matt Parrish, Head of Investor Relations
  • Ms. Amanda Miller, Gen. Counsel & Company Sec.

What is Clinigen Group's stock symbol?

Clinigen Group trades on the OTCMKTS under the ticker symbol "CLIGF."

How do I buy shares of Clinigen Group?

Shares of CLIGF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Clinigen Group's stock price today?

One share of CLIGF stock can currently be purchased for approximately $8.40.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of $1.03 billion and generates $635.82 million in revenue each year. The company earns $17.27 million in net income (profit) each year or $0.81 on an earnings per share basis. Clinigen Group employs 1,150 workers across the globe.

What is Clinigen Group's official website?

The official website for Clinigen Group is www.clinigengroup.com.

How can I contact Clinigen Group?

Clinigen Group's mailing address is PITCAIRN HOUSE CROWN SQUARE FIRST AVENUE, Burton-on-Trent X0, DE14 2WW. The company can be reached via phone at 44-12-8349-5010.

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.